Advancing Nanobiotechnology

                for Novel siRNA Therapeutics

Management

Patrick Lu, Ph.D.

Chairman

John J. Xu, MD

General Manager

Alan Y. Lu

Chief Scientist

© 2007-2021 by Sirnaomics, Inc.